Planning for hemorrhage: Steps an anesthesiologist can take to limit and treat hemorrhage in the obstetric patient

Anesthesiology Clinics of North America

Volumn 21, Issue 1, 2003, Pages 127-144

  Esler, Mark D ^a   Douglas, M Joanne ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; CARBOPROST TROMETAMOL; ERGOMETRINE; FOLIC ACID; IRON; OXYTOCIN; RECOMBINANT ERYTHROPOIETIN;

BLEEDING; BLOOD TRANSFUSION; FEMALE; HUMAN; MATERNAL MORBIDITY; OBSTETRIC ANESTHESIA; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT PLANNING;

ANESTHESIA, OBSTETRICAL; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CESAREAN SECTION; FEMALE; HEMORRHAGE; HUMANS; OBSTETRIC LABOR COMPLICATIONS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS;

EID: 0037349497     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(02)00027-5     Document Type: Article

References (111)

1. Bogod DG. A long and dangerous journey: maternal mortality in Africa. Anaesthesia 1999;54:1025-7.
2. Fenton PM. Blood transfusion for Caesarean section in Malawi: a study of requirements, amount given and effect on mortality. Anaesthesia 1999;54:1055-8.
3. Lewis G, Drife J. Why mothers die 1997-99: the fifth report on the confidential enquiries into maternal deaths in the United Kingdom. London: Royal College of Obstetrics and Gynaecology Press; 2001.
4. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case control study. BMJ 2001;322:1089-94.
5. Kamani AA, McMorland GH, Wadsworth LD. Utilization of red blood cell transfusion in an obstetric setting. Am J Obstet Gynecol 1988;159:1177-81.
6. Klapholz H. Blood transfusion in contemporary obstetric practice. Obstet Gynaecol 1990;75:940-3.
7. Morrison JC, Sumrall DD, Chevalier SP, et al. The effect of provider education on blood utilization practices. Am J Obstet Gynecol 1993;169:1240-5.
8. Rosaeg OP, Yarnell RW, Lindsay MP. The obstetrical anaesthesia assessment clinic: a review of six years experience. Can J Anaesth 1993;40:346-56.
9. Pahlavan P, Nezhat C, Nezhat C. Hemorrhage in obstetrics and gynecology. Curr Opin Obstet Gynecol 2001;13:419-24.
10. Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth 2000;85:487-91.
11. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. N Engl J Med 1999;340:438-47.
12. Hewlett IH, Epstein JS. Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening. Transfusion 1997;37:346-51.
13. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
14. Physician's Guide 2001. Informed consent for blood and blood products. In: Pi D, Wadsworth L, editors. Appendix A. Vancouver, B.C.: British Columbia Provincial Blood Coordinating Office; 2001. p. 49-50.
15. Ophir E, Tendler R, Odeh M, et al. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta. Am J Obstet Gynecol 1999;180:1039-40.
16. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv 1998;53:509-17.
17. Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992;11:333-43.
18. Guy GP, Peisner DB, Timor-Tritsch IE. Ultrasonographic evaluation of uteroplacental blood flow patterns of abnormally located and adherent placenta. Am J Obstet Gynecol 1990;163:723-7.
19. Chou MM, Ho ESC, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
20. Thorp Jr JM, Councell RB, Sandridge DA, et al. Antepartum diagnosis of placenta previa percreta by magnetic resonance imaging. Obstet Gynecol 1992;80:506-8.
21. Goodnough LT. Controversies in autologous blood procurement. Br J Anaesth 1998;81(Suppl 1):67-72.
22. Mahomed K. Iron and folate supplementation in pregnancy. (Cochrane review) In: The Cochrane Library, Oxford: Update Software. Issue 4, 2002.
23. Vora M, Gruslin A. Erythropoietin in obstetrics. Obstet Gynecol Surv 1998;53:500-8.
24. Harstad TW, Mason RA, Cox SM. Serum erythropoietin quantitation in pregnancy using enzyme-linked immunoassay. Am J Perinatol 1992;9:233-5.
25. Widness JA, Clemons GK, Garcia JF, et al. Plasma immunoreactive erythropoietin in normal women studied sequentially during and after pregnancy. Am J Obstet Gynecol 1984;149:646-50.
26. Yankowitz J, Piraino B, Laifer SA, et al. Erythropoietin in pregnancies complicated by severe anemia of renal failure. Obstet Gynecol 1992;80:485-8.
27. Szurkowski M, Wiecek A, Kokot F, et al. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant. Nephron 1994;67:242-3.
28. Hou S, Orlowski J, Pahl M, et al. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 1993;21:16-22.
29. Harris SA, Payne Jr G, Putman JM. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy. Obstet Gynecol 1996;87:812-4.
30. Danko J, Huch R, Huch A. Epoetin alpha for treatment of postpartum anaemia [letter]. Lancet 1990;335:737-8.
31. Sifakis S, Angelakis E, Vardaki E, et al. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest 2001;51:150-6.
32. Biesma DH, Marx JJM, Kraaijenhagen RJ, et al. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367-70.
33. Goodnough LT. Erythropoietin therapy versus red cell transfusion. Curr Opin Hematol 2001;8:405-10.
34. 125l-erythropoietin by the placenta. J Clin Invest 1988;82:154-9.
35. 125I-labelled erythropoietin in sheep. J Dev Physiol 1991;15:139-43.
36. Reisenberger K, Egarter C, Kapiotis S, et al. Transfer of erythropoietin across the placenta perfused in vitro. Obstet Gynecol 1997;89:738-42.
37. Braga J, Marques R, Branco A, et al. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996;75:449-53.
38. Glaspy J, Jadeja JS, Justice G, et al. A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer 2001;84(Suppl 1):17-23.
39. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001;84(Suppl 1):3-10.
40. Combs CA, Murphy EL, Laros Jr RK. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 1991;77:77-82.
41. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. II: Blood conservation. N Engl J Med 1999;340:525-33.
42. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000;96:823-33.
43. Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 2000;93:242-55.
44. McVay PA, Hoag RW, Hoag MS, et al. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol 1989;160:1479-88.
45. Droste S, Sorensen T, Price T, et al. Maternal and fetal hemodynamic effects of autologous blood donation during pregnancy. Am J Obstet Gynecol 1992;167:89-93.
46. Bengtsson A, Bengtson JP. Autologous blood transfusion: preoperative blood collection and blood salvage techniques. Acta Anaesthesiol Scand 1996;40:1041-56.
47. Combs CA, Murphy EL, Laros Jr RK. Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 1992;80:621-5.
48. Report of the Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997;156(11 Suppl):1-12.
49. Thomas MJ, Gillon J, Desmond MJ. Consensus conference on autologous transfusion. Preoperative autologous donation. Transfusion 1996;36:633-9.
50. Cameron CB, Kobrinsky N. Perioperative management of patients with von Willebrand's disease. Can J Anaesth 1990;37:341-7.
51. Furie B, Limentani SA, Rosenfield CG. A practical guide to the evaluation and treatment of hemophilia. Blood 1994;84:3-9.
52. Alving BM. Management of congenital and acquired hemostatic disorders during pregnancy. In: Sacher RA, Brecher ME, editors. Obstetric transfusion practice. Bethesda: American Association of Blood Banks; 1993. p. 117-34.
53. Vamvakas EC, Pineda AA. Autologous transfusion and other approaches to reduce allogeneic blood exposure. Bailliere's Clin Haematol 2000;13:533-47.
54. Monk TG, Goodnough LT, Brecher ME, et al. Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg 1997;85:953-8.
55. Smetannikov Y, Hopkins D. Intraoperative bleeding: a mathematical model for minimizing hemoglobin loss. Transfusion 1996;36:832-5.
56. Weisfopf RB. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 2001;94:439-46.
57. Grange CS, Douglas MJ, Adams TJ, et al. The use of acute hemodilution in parturients undergoing cesarean section. Am J Obstet Gynecol 1998;178:156-60.
58. Estella NM, Berry DL, Baker BW, et al. Normovolemic hemodilution before cesarean hysterectomy for placenta percreta. Obstet Gynecol 1997;90:669-70.
59. Frederiksen MC, Glassenberg R, Stika CS. Placenta previa: a 22-year analysis. Am J Obstet Gynecol 1999;180:1432-7.
60. Parekh N, Husaini SWU, Russell IF. Caesarean section for placenta praevia: a retrospective study of anaesthetic management. Br J Anaesth 2000;84:725-30.
61. Hood DD, Holubec DM. Elective repeat cesarean section: effect of anesthesia type on blood loss. J Reprod Med 1990;35:368-72.
62. Bonner SM, Haynes SR, Ryall D. The anaesthetic management of caesarean section for placenta praevia: a questionnaire survey. Anaesthesia 1995;50:992-4.
63. Plumer MH, Rottman R. How anesthesiologists practice obstetric anesthesia. Reg Anesth 1996;21:49-60.
64. Santoso JT, Lin DW, Miller DS. Transfusion medicine in obstetrics and gynecology. Obstet Gynecol Surv 1995;50:470-81.
65. Hutchinson AB, Fergusson D, Graham ID, et al. Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med 2001;11:79-85.
66. Camann W. Cell salvage during cesarean delivery: is it safe and valuable? Maybe, maybe not! [editorial]. International Journal of Obstetric Anesthesia 1999;8:75-6.
67. Clark SL, Hankins GDV, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995;172:1158-69.
68. Yentis SM. Sudden obstetric collapse syndrome [letter]. International Journal of Obstetric Anesthesia 1999;8:296.
69. Catling S. Cell salvage: how safe in obstetrics? [reply]. International Journal of Obstetric Anesthesia 2000;9:143-4.
70. Jackson SH, Lonser RE. Safety and effectiveness of intracesarean blood salvage [letter]. Transfusion 1993;33:181.
71. Oei SG, Wingen CBM, Kerkkamp HEM. Cell salvage: how safe in obstetrics? [letter]. International Journal of Obstetric Anesthesia 2000;9:143.
72. Potter PS, Waters JH, Burger GA, et al. Application of cell-salvage during cesarean section. Anesthesiology 1999;90:619-21.
73. Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth 1998;80:195-8.
74. Rebarber A, Lonser R, Jackson S, et al. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 1998;179:715-20.
75. Catling SJ, Williams S, Fielding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leukocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. International Journal of Obstetric Anesthesia 1999;8:79-84.
76. Durand F, Duchesne-Gueguen M, Le Bervet JY, et al. Rheologic and cytologic study of autologous blood collected with Cell Saver 4 during cesarean. Revuew Francaise de Transfusion et D Hemobiologie 1989;32:179-91.
77. Bernstein HH, Rosenblatt MA, Gettes M, et al. The ability of the Haemonetics 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg 1997;85:831-3.
78. Khong TY. Expression of endothelin-1 in amniotic fluid embolism and possible pathophysiological mechanism. Br J Obstet Gynaecol 1998;105:802-4.
79. Weiskopf RB. Erythrocyte salvage during cesarean section [editorial]. Anesthesiology 2000;92:1519-22.
80. Halpern NA, Alicea M, Seabrook B, et al. Isolyte S, a physiologic multielectrolyte solution, is preferable to normal saline to wash cell saver salvaged blood: conclusions from a prospective, randomized study in a canine model. Crit Care Med 1997;25:2031-8.
81. Linden JV, Kaplan HS, Murphy MT. Fatal air embolism due to perioperative blood recovery. Anesth Analg 1997;84:422-6.
82. Alvarez M, Lockwood CJ, Ghidini A, et al. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol 1992;9:441-4.
83. Levine AB, Kuhlman K, Bonn J. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med 1999;8:173-6.
84. Magann EF, Dodson MK, Allbert JR, et al. Blood loss at time of cesarean section by method of placental removal and exteriorization versus in situ repair of the uterine incision. Surg Gynecol Obstet 1993;177:389-92.
85. McCurdy Jr CM, Magann EF, McCurdy CJ, et al. The effect of placental management at cesarean delivery on operative blood loss. Am J Obstet Gynecol 1992;167:1363-7.
86. Legro RS, Price FV, Hill LM, et al. Nonsurgical management of placenta percreta: a case report. Obstet Gynecol 1994;83:847-9.
87. Mayer DC. Hemorrhagic obstetric emergencies. Seminars in Anesthesia 1992;11:32-42.
88. Mategrano VA, Gabay MP. Misoprostol in the prevention of postpartum hemorrhage. Ann Pharmacother 2001;35:1648-52.
89. Weiskopf RB. Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic transfusion. Transfusion 1995;35:37-41.
90. Ekeroma AJ, Ansari A, Stirrat GM. Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol 1997;104:278-84.
91. American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guidelines for blood component therapy. Anesthesiology 1996;84:732-47.
92. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217-21.
93. Consensus Development Panel. Consensus conference: perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
94. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
95. Naef III RW, Washbume JF, Martin RW, et al. Hemorrhage associated with cesarean delivery: when is transfusion needed? J Perinatol 1995;15:32-5.
96. As AK, Hagen P, Webb JB. Tranexamic acid in the management of postpartum haemorrhage. Br J Obstet Gynaecol 1996;103:1250-1.
97. Miller RD, Robbins TO, Tong MJ, et al. Coagulation defects associated with massive blood transfusions. Ann Surg 1971;174:794-801.
98. Kelly JV. Postpartum hemorrhage. Clin Obstet Gynecol 1976;19:595-606.
99. Keogh J, Tsokos N. Aortic compression in massive postpartum haemorrhage: an old but life-saving technique. Aust N Z J Obstet Gynaecol 1997;37:237-8.
100. Riley DP, Burgess RW. External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage. Anaesth Intensive Care 1994;22:571-5.
101. McSwain Jr NE. Pneumatic anti-shock garment: state of the art 1988. Ann Emerg Med 1988;17:506-25.
102. Andrae B, Eriksson LG, Skoog G. Anti-shock trousers (MAST) and transcatheter embolization in the management of massive obstetric hemorrhage: a report of two cases. Acta Obstet Gynecol Scand 1999;78:740-1.
103. Maier RC. Control of postpartum haemorrhage with uterine packing. Am J Obstet Gynecol 1993;169:317-23.
104. Wax JR, Channell JC, Vandersloot JA. Packing of the lower uterine segment: new approach to an old technique? [letter]. Int J Gynaecol Obstet 1993;43:197-8.
105. Bowen LW, Beeson JH. Use of a large Foley catheter balloon to control postpartum hemorrhage resulting from a low placental implantation: a report of two cases. J Reprod Med 1985;30:623-5.
106. Katesmark M, Brown R, Raju KS. Successful use of a Sengstaken-Blakemore tube to control massive postpartum haemorrhage. Br J Obstet Gynaecol 1994;101:259-60.
107. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for obstetrical bleeding. Int J Gynecol Obstet 2001;74:139-42.
108. Bhavani-Shankar K, Lynch EP, Datta S. Airway changes during cesarean hysterectomy. Can J Anaesth 2000;47:338-41.
109. Levy JH. Hemoglobin-based oxygen-carrying solutions: close but still so far [editorial]. Anesthesiology 2000;92:639-41.
110. Vlahakes GJ. Hemoglobin solutions come of age [editorial]. Anesthesiology 2000;92:637-8.
111. Jones JA. Red blood cell substitutes: current status. Br J Anaesth 1995;74:697-703.